Synthesis and radioprotective study of new siladithioacetals and germadithioacetals

被引:5
作者
Célariès, B
Amourette, C
Lion, C
Rima, G
机构
[1] Univ Toulouse 3, CNRS, UMR 5069, Lab Heterochim Fondamentale & Appl, F-31062 Toulouse 4, France
[2] Ctr Rech Serv Sante Armees, F-38702 La Tronche, France
[3] Univ Paris 07, CNRS, ITODYS, F-75005 Paris, France
关键词
siladithioacetals; germadithioacetals; toxicity; LD50; naphthylethylimidazoline; radioprotective activity;
D O I
10.1002/aoc.472
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A series of organosilicon and organogermanium compounds derived from cysteamine, methylcysteamine and 2-[1-(1-naphthyl)ethyl]-2-imidazoline have been prepared and their radiopharmacological properties (radioprotective activity and toxicity) have been determined in mice. A number of these new organometallic derivatives have been found to possess radioprotective activity. We have also noted a notable decrease of the toxicity and a fairly large increase in the radioprotective activity in comparison with the unsubstituted organic molecules. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 54 条
[1]   SUBCHRONIC ORAL TOXICITY (6 MONTHS) OF CARBOXYETHYLGERMANIUM SESQUIOXIDE [(HOOCCH2CH2GE)2O3]N IN RATS [J].
ANGER, F ;
ANGER, JP ;
GUILLOU, L ;
PAPILLON, A ;
JANSON, C ;
SUBLET, Y .
APPLIED ORGANOMETALLIC CHEMISTRY, 1992, 6 (03) :267-272
[2]   INDUCTION OF INTERFERON AND ACTIVATION OF NK CELLS AND MACROPHAGES IN MICE BY ORAL-ADMINISTRATION OF GE-132, AN ORGANIC GERMANIUM COMPOUND [J].
ASO, H ;
SUZUKI, F ;
YAMAGUCHI, T ;
HAYASHI, Y ;
EBINA, T ;
ISHIDA, N .
MICROBIOLOGY AND IMMUNOLOGY, 1985, 29 (01) :65-74
[3]  
ATASSI G, 1985, REV SI GE SN PB COMP, V8, P219
[4]   GENERATION OF SUPPRESSOR CELLS IN NORMAL RATS BY TREATMENT WITH SPIROGERMANIUM, A NOVEL HETEROCYCLIC ANTICANCER DRUG [J].
BADGER, AM ;
MIRABELLI, CK ;
DIMARTINO, M .
IMMUNOPHARMACOLOGY, 1985, 10 (03) :201-207
[5]  
BONET-MAURY P, 1950, J Radiol Electrol Arch Electr Medicale, V31, P286
[6]  
BOROS L, 1986, CANCER TREAT REP, V70, P917
[7]  
BRENNER DE, 1985, CANCER TREAT REP, V69, P457
[8]  
Célariès B, 2002, MAIN GROUP MET CHEM, V25, P58
[9]  
Celaries Benoit, 2001, Metal-Based Drugs, V8, P199, DOI 10.1155/MBD.2001.199
[10]   PREPARATION AND PROPERTIES OF TRIPODAL AND LINEAR TETRADENTATE N,S-DONOR LIGANDS AND THEIR COMPLEXES CONTAINING THE MOO22+ CORE [J].
CORBIN, JL ;
MILLER, KF ;
PARIYADATH, N ;
WHERLAND, S ;
BRUCE, AE ;
STIEFEL, EI .
INORGANICA CHIMICA ACTA-ARTICLES AND LETTERS, 1984, 90 (01) :41-51